Planta Med 2004; 70(3): 193-196
DOI: 10.1055/s-2004-815533
Review
© Georg Thieme Verlag Stuttgart · New York

Kava Hepatotoxicity: Are we any Closer to the Truth?

Jennifer Anke1 , 2 , Iqbal Ramzan1
  • 1Faculty of Pharmacy, University of Sydney, Sydney, NSW, Australia
  • 2Faculty of Chemistry and Pharmacy, Westfälische Wilhelms-University Münster, Germany
Further Information

Publication History

Received: December 1, 2003

Accepted: January 31, 2004

Publication Date:
23 March 2004 (online)

Abstract

In recent years, kava kava (Piper methysticum, Forst. f., Piperaceae) has been implicated in a number of liver failure cases. Ever since this has kept the scientific world busy. Even though, on closer inspection, the majority of the case reports are probably not connected to kava intake, hepatotoxic effects of kava cannot generally be ruled out. In this article the major theories as to the mechanism of kava hepatotoxicity are summarized. But in spite of all these hypotheses, there is still no satisfactory answer. In any case, further studies, that might hopefully restore the reputation of kava, are required.

References

  • 1 BfArM (Federal Institute for Drugs and Medicinal Products in Germany): http://www.bfarm.de/de/Arzneimittel/am_sicher/stufenpl/Besch-Kava-Final.pdf. 
  • 2 Russmann S, Lauterburg B H, Helbling A. Kava hepatotoxicity.  Ann Intern Med. 2001;  135 68-9
  • 3 Campo J V, McNabb J, Perel J M, Mazariegos G V, Hasegawa S L, Reyes J. Kava-induced fulminant hepatic failure.  J Am Acad Child Adolesc Psychiatry. 2002;  41 631-2
  • 4 McGhee H W. Hepatic toxicity possibly associated with kava-containing products - United States, Germany and Switzerland 1999 - 2002.  JAMA. 2003;  289 36-7
  • 5 Gow P J, Connelly N J, Hill R L, Crowley P, Angus P W. Fatal fulminant hepatic failure induced by a natural therapy containing kava.  MJA. 2003;  178 442-3
  • 6 Brauer R B, Stangl M, Stewart J R, Pfab R, Becker K. Acute liver failure after administration of the herbal tranquilizer kava-kava (Piper methysticum).  J Clin Psychiatry. 2003;  64 216-8
  • 7 Stickel F, Baumüller H -M, Seitz K, Vasilakis D, Seitz G, Seitz H K, Schuppan D. Hepatitis induced by kava (Piper methysticum rhizoma).  J Hepatol. 2003;  39 62-7
  • 8 Strahl S, Ehret V, Dahm H H, Maier K P. Necrotizing hepatitis after taking herbal remedies.  Dtsch Med Wochenschr. 1998;  123 1410-4
  • 9 Schmidt M, Nahrstedt A. Ist kava lebertoxisch?.  Dtsch Apoth Ztg. 2002;  142 1006-11
  • 10 Teschke R. Kava, kavapyrones and toxic liver injury.  Z Gastroenterol. 2003;  41 395-404
  • 11 Schmidt M. Are kavalactones the hepatotoxic principle of kava extracts? The pitfalls of the glutathione theory.  J Altern Complement Med. 2003;  64 673-9
  • 12 Bauer R, Kopp B, Nahrstedt A. Relevant hepatotoxic effects of kava still need to be proven.  Planta Med. 2003;  69 971-2
  • 13 Teschke R, Gaus W, Loew D. Kava extracts: safety and risks including rare hepatotoxicity.  Phytomedicine. 2003;  10 440-6
  • 14 Loew D, Gaus W. Kava (Piper methysticum): The tragedy of a wrong judgement.  Z Phytother. 2002;  23 267-81
  • 15 Mills S Y, Steinhoff B. Kava-kava: a lesson for the phytomedicine community.  Phytomedicine. 2003;  10 261-2

Iqbal Ramzan

Faculty of Pharmacy

University of Sydney

Sydney

NSW 2006

Australia

Phone: +61-2-9351-2324

Fax: +61-2-9351-4391

Email: iqbalr@pharm.usyd.edu.au